Andrew S Allegretti MD
Clinical Fellow in Medicine, Massachusetts General Hospital
Join to View Full Profile
Massachusetts General Hospital55 Fruit StBoston, MA 02114
Phone+1 617-726-5050
Fax+1 617-724-7441
Dr. Allegretti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2013 - 2017
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2010 - 2013
The Warren Alpert Medical School of Brown UniversityClass of 2010
Certifications & Licensure
MA State Medical License 2012 - 2027
Publications & Presentations
PubMed
- Physiologic Solutions are Superior to Normal Saline in Critically Ill Patients: CON.Andrew Z Fenves, Andrew S Allegretti
Kidney360. 2025-03-20 - Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.Elisa Pose, César Jiménez, Giacomo Zaccherini, Daniela Campion, Salvatore Piano
JAMA. 2025-03-11 - The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: a post hoc analysis.Giuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar, Khurram Jamil, Juan Carlos Q Velez
Hepatology. 2025-03-07
Journal Articles
- Serum Angiopoietin‐2 Predicts Mortality and Kidney Outcomes in Decompensated CirrhosisAndrew S Allegretti, Sagar U Nigwekar, Raymond T Chung, Sahir Kalim, Xavier Vela Parada, Ravi I Thadhani, Guillermo A Ortiz, Samir M Parikh, Hepatology
Press Mentions
How Acute Kidney Injury Impacts Patients Awaiting Liver TransplantSeptember 6th, 2024- VIDEO: Serum Creatinine Linked to Adverse Events in HRS-AKI Treated with TerlipressinNovember 24th, 2021
- VIDEO: Early Treatment with Terlipressin Benefits Patients with Hepatorenal SyndromeNovember 20th, 2020
- Join now to see all
Grant Support
- Personalizing Therapies for Acute Kidney Injury in CirrhosisMASSACHUSETTS GENERAL HOSPITAL2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
